» Articles » PMID: 25671161

Caveolin-1 and CDC42 Mediated Endocytosis of Silica-coated Iron Oxide Nanoparticles in HeLa Cells

Overview
Specialty Biotechnology
Date 2015 Feb 12
PMID 25671161
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Nanomedicine is a rapidly growing field in nanotechnology, which has great potential in the development of new therapies for numerous diseases. For example iron oxide nanoparticles are in clinical use already in the thermotherapy of brain cancer. Although it has been shown, that tumor cells take up these particles in vitro, little is known about the internalization routes. Understanding of the underlying uptake mechanisms would be very useful for faster and precise development of nanoparticles for clinical applications. This study aims at the identification of key proteins, which are crucial for the active uptake of iron oxide nanoparticles by HeLa cells (human cervical cancer) as a model cell line. Cells were transfected with specific siRNAs against Caveolin-1, Dynamin 2, Flotillin-1, Clathrin, PIP5Kα and CDC42. Knockdown of Caveolin-1 reduces endocytosis of superparamagnetic iron oxide nanoparticles (SPIONs) and silica-coated iron oxide nanoparticles (SCIONs) between 23 and 41%, depending on the surface characteristics of the nanoparticles and the experimental design. Knockdown of CDC42 showed a 46% decrease of the internalization of PEGylated SPIONs within 24 h incubation time. Knockdown of Dynamin 2, Flotillin-1, Clathrin and PIP5Kα caused no or only minor effects. Hence endocytosis in HeLa cells of iron oxide nanoparticles, used in this study, is mainly mediated by Caveolin-1 and CDC42. It is shown here for the first time, which proteins of the endocytotic pathway mediate the endocytosis of silica-coated iron oxide nanoparticles in HeLa cells in vitro. In future studies more experiments should be carried out with different cell lines and other well-defined nanoparticle species to elucidate possible general principles.

Citing Articles

Enhanced Delivery and Potency of Chemotherapeutics in Melanoma Treatment via Magnetite Nanobioconjugates.

Diaz E, Quezada V, Cifuentes J, Arias Morales N, Reyes L, Munoz-Camargo C ACS Omega. 2024; 9(45):45402-45420.

PMID: 39554413 PMC: 11561594. DOI: 10.1021/acsomega.4c07415.


(Nano)biotechnological approaches in the treatment of cervical cancer: integration of engineering and biology.

Xie W, Xu Z Front Immunol. 2024; 15:1461894.

PMID: 39346915 PMC: 11427397. DOI: 10.3389/fimmu.2024.1461894.


Unveiling Nanoparticles: Recent Approaches in Studying the Internalization Pattern of Iron Oxide Nanoparticles in Mono- and Multicellular Biological Structures.

Petcov T, Straticiuc M, Iancu D, Mirea D, Trusca R, Mereuta P J Funct Biomater. 2024; 15(6).

PMID: 38921542 PMC: 11204647. DOI: 10.3390/jfb15060169.


Nanomaterials in Medicine: Understanding Cellular Uptake, Localization, and Retention for Enhanced Disease Diagnosis and Therapy.

Peng Y, Yang Z, Sun H, Li J, Lan X, Liu S Aging Dis. 2024; .

PMID: 38421835 PMC: 11745437. DOI: 10.14336/AD.2024.0206-1.


Caveolin-Mediated Internalization of Fmoc-FF Nanogels in Breast Cancer Cell Lines.

Smaldone G, Rosa E, Gallo E, Diaferia C, Morelli G, Stornaiuolo M Pharmaceutics. 2023; 15(3).

PMID: 36986886 PMC: 10051563. DOI: 10.3390/pharmaceutics15031026.


References
1.
Villanueva A, Canete M, Roca A, Calero M, Veintemillas-Verdaguer S, Serna C . The influence of surface functionalization on the enhanced internalization of magnetic nanoparticles in cancer cells. Nanotechnology. 2009; 20(11):115103. DOI: 10.1088/0957-4484/20/11/115103. View

2.
Hinshaw J . Dynamin and its role in membrane fission. Annu Rev Cell Dev Biol. 2000; 16:483-519. PMC: 4781412. DOI: 10.1146/annurev.cellbio.16.1.483. View

3.
Laurent S, Dutz S, Hafeli U, Mahmoudi M . Magnetic fluid hyperthermia: focus on superparamagnetic iron oxide nanoparticles. Adv Colloid Interface Sci. 2011; 166(1-2):8-23. DOI: 10.1016/j.cis.2011.04.003. View

4.
Ma Y, Gu H . Study on the endocytosis and the internalization mechanism of aminosilane-coated Fe3O4 nanoparticles in vitro. J Mater Sci Mater Med. 2007; 18(11):2145-9. DOI: 10.1007/s10856-007-3015-8. View

5.
Pyshnaya I, Razum K, Poletaeva J, Pyshnyi D, Zenkova M, Ryabchikova E . Comparison of behaviour in different liquids and in cells of gold nanorods and spherical nanoparticles modified by linear polyethyleneimine and bovine serum albumin. Biomed Res Int. 2014; 2014:908175. PMC: 4100455. DOI: 10.1155/2014/908175. View